Two new drugs to be licensed during this year

Published: 2002-06-25 07:00:00

Updated: 2002-06-25 07:00:00

This year will witness another market authorization of two new drugs developed by domestic pharmaceutical firms Gu-ju's antiarthritic agent Apitoxin inj. and LGCI's quinolone antibiotitc Factive, following the already licensed 4 new drugs; SK Chemical's Sunpla inj. Daewoong's EGF, Choong-wae's Quroxin, and Dongwha's Milican inj.

Apitoxin is found to be effective in the treatment of osteoart...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.